文献速递脑血管病

大规模血浆蛋白质组学特征预测普通人群缺血性卒中风险

Large-Scale Plasma Proteomics Profiles for Predicting Ischemic Stroke Risk in the General Population.
PubMed 文献 · Stroke · 2024-12-20

研究基于英国生物银行药物蛋白质组学项目的前瞻性队列,纳入43030名参与者,构建并验证由17种蛋白质组成的缺血性卒中蛋白质风险评分。在中位随访13.6年间发生989例缺血性卒中,该评分在内外部验证集中均显示出对缺血性卒中风险的预测能力,优于临床风险因素和多基因风险评分。

要点

  • 缺血性卒中蛋白质风险评分由17种蛋白质构成,在内部验证集中C统计量为0.765(95%CI 0.736-0.793)。
  • 仅用前5种蛋白质的累积C统计量为0.761(95%CI 0.733-0.790),预测能力接近完整评分。
  • 包含年龄、性别和蛋白质风险评分的简单模型对缺血性卒中风险具有良好的预测性能。

核心结论

  • 包含年龄、性别和缺血性卒中蛋白质风险评分(或仅前5种蛋白质)的简单模型对缺血性卒中风险具有良好的预测性能。

研究设计与样本

  • 前瞻性队列研究,纳入英国生物银行药物蛋白质组学项目中43030名参与者(平均年龄59.0岁,女性占54.0%),其中38060名来自英格兰的参与者按7:3随机分为训练集和内部验证集,4970名来自苏格兰/威尔士的参与者作为外部验证集。

主要发现

  • 在中位随访13.6年期间,共发生989例缺血性卒中。
  • 在训练集中,缺血性卒中蛋白质风险评分由2911种蛋白质中的17种构建。
  • 在内部验证集中,缺血性卒中蛋白质风险评分的C统计量为0.765(95%CI 0.736-0.793),高于基础模型(年龄和性别)的0.720(95%CI 0.691-0.749)、缺血性卒中临床风险因素的0.753(95%CI 0.725-0.781)和缺血性卒中多基因风险评分的0.730(95%CI 0.701-0.759)。
  • 缺血性卒中蛋白质风险评分中绝对系数最大的前5种蛋白质(GDF15、PLAUR、NT-proBNP、IGFBP4和BCAN)贡献了大部分预测能力,累积C统计量为0.761(95%CI 0.733-0.790)。
  • 上述结果在外部验证队列中得到验证。

关键数值与推荐

  • 缺血性卒中蛋白质风险评分通过最小绝对收缩和选择算子回归选择的蛋白质加权和计算。
  • 模型区分能力通过C统计量评估。
  • 缺血性卒中临床风险因素包括年龄、性别、吸烟、腰臀比、降压药物使用、收缩压和舒张压、冠心病、糖尿病、总胆固醇/高密度脂蛋白胆固醇比值和估算肾小球滤过率。
  • 多基因风险评分使用已识别的易感变异计算。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aimed to develop and validate a protein risk score for ischemic stroke (IS) risk prediction and to compare its predictive capability with IS clinical risk factors and IS polygenic risk score. METHODS: The prospective cohort study included 53 029 participants from UKB-PPP (UK Biobank Pharmaceutical Proteomics Project). IS protein risk score was calculated as the weighted sum of proteins selected by the least absolute shrinkage and selection operator regression. The discrimination ability of models was assessed by C statistic. IS risk factors included age, sex, smoking, waist-to-hip ratio, antihypertensive medication use, systolic and diastolic blood pressure, coronary heart disease, diabetes, total cholesterol/high-density lipoprotein cholesterol ratio, and estimated glomerular filtration rate. Polygenic risk score was computed using identified susceptibility variants. RESULTS: After exclusions, 38 060 participants from England were randomly divided into the training set and the internal validation set in a 7:3 ratio, and 4970 participants from Scotland/Wales were assigned as the external validation set. Of 43 030 participants included (mean age, 59.0 years; 54.0% female), 989 incident IS occurred during a median follow-up of 13.6 years. In the training set, IS protein risk score was constructed using 17 out of 2911 proteins. In the internal validation set, compared with the basic model (age and sex: C statistic,0.720 [95% CI, 0.691-0.749]), IS protein risk score had the highest predictive performance for IS risk (C statistic, 0.765 [95% CI, 0.736-0.793]), followed by clinical risk factors of IS (C statistic, 0.753 [95% CI, 0.725-0.781]), and IS polygenic risk score (C statistic, 0.730 [95% CI, 0.701-0.759]). The top 5 proteins with the largest absolute coefficients in the IS protein risk score, including GDF15 (growth/differentiation factor 15), PLAUR (urokinase plasminogen activator surface receptor), NT-proBNP (N-terminal pro-B-type natriuretic peptide), IGFBP4 (insulin-like growth factor-binding protein 4), and BCAN (brevican core protein), contributed most of the predictive ability of the IS protein risk score, with a cumulative C statistic of 0.761 (95% CI, 0.733-0.790). These results were verified in the external validation cohort. CONCLUSIONS: A simple model, including age, sex, and the IS protein risk score (or only the top 5 proteins) had a good predictive performance for IS risk.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gan X, Yang S, Zhang Y, et al. Large-Scale Plasma Proteomics Profiles for Predicting Ischemic Stroke Risk in the General Population. Stroke. 2024. PMID: 39704077. doi:10.1161/STROKEAHA.124.048654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。